1. Home
  2. ONC vs WIT Comparison

ONC vs WIT Comparison

Compare ONC & WIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • WIT
  • Stock Information
  • Founded
  • ONC 2010
  • WIT 1945
  • Country
  • ONC Switzerland
  • WIT India
  • Employees
  • ONC N/A
  • WIT N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • WIT EDP Services
  • Sector
  • ONC Health Care
  • WIT Technology
  • Exchange
  • ONC Nasdaq
  • WIT Nasdaq
  • Market Cap
  • ONC 26.9B
  • WIT 29.9B
  • IPO Year
  • ONC N/A
  • WIT N/A
  • Fundamental
  • Price
  • ONC $245.58
  • WIT $2.87
  • Analyst Decision
  • ONC Strong Buy
  • WIT Hold
  • Analyst Count
  • ONC 7
  • WIT 1
  • Target Price
  • ONC $326.43
  • WIT N/A
  • AVG Volume (30 Days)
  • ONC 368.4K
  • WIT 4.6M
  • Earning Date
  • ONC 05-07-2025
  • WIT 07-18-2025
  • Dividend Yield
  • ONC N/A
  • WIT 1.07%
  • EPS Growth
  • ONC N/A
  • WIT 20.27
  • EPS
  • ONC N/A
  • WIT 0.15
  • Revenue
  • ONC $4,180,740,829.00
  • WIT $10,426,195,411.00
  • Revenue This Year
  • ONC $32.78
  • WIT $3.12
  • Revenue Next Year
  • ONC $19.07
  • WIT $5.33
  • P/E Ratio
  • ONC N/A
  • WIT $19.88
  • Revenue Growth
  • ONC 52.09
  • WIT N/A
  • 52 Week Low
  • ONC $141.31
  • WIT $2.55
  • 52 Week High
  • ONC $287.88
  • WIT $3.79
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • WIT 46.42
  • Support Level
  • ONC N/A
  • WIT $2.86
  • Resistance Level
  • ONC N/A
  • WIT $2.91
  • Average True Range (ATR)
  • ONC 0.00
  • WIT 0.05
  • MACD
  • ONC 0.00
  • WIT -0.00
  • Stochastic Oscillator
  • ONC 0.00
  • WIT 15.00

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About WIT Wipro Limited

Wipro is a leading global IT services provider, with over 234,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive a significant portion of its revenue from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.

Share on Social Networks: